Informed Consent for Human Embryo Genome Editing
- PMID: 32294411
- PMCID: PMC7160388
- DOI: 10.1016/j.stemcr.2020.03.010
Informed Consent for Human Embryo Genome Editing
Abstract
In the event that human embryo genome editing is considered safe enough for the clinic, researchers will need to consider how to administer consent so that would-be recipients of edited embryos can make an informed decision. Informed consent will require truthfulness, sensitivity, regulatory compliance, and attention to the highest ethical standards.
Copyright © 2020 The Author. Published by Elsevier Inc. All rights reserved.
References
-
- Appelbaum P.S., Roth L.H., Lidz C.W., Benson P., Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent. Rep. 1987;17:20–24. - PubMed
-
- Botkin J.R. The case for banning heritable genome editing. Genet. Med. 2019;22:487–489. - PubMed
-
- Burger I.M., Wilfond B.S. Limitations of informed consent for in utero gene transfer research: implications for investigators and institutional review boards. Hum. Gene Ther. 2000;11:1057–1063. - PubMed
-
- Cwik B. Designing ethical trials of germline gene editing. N. Engl. J. Med. 2017;377:1911–1913. - PubMed
-
- Daley G.Q., Lovell-Badge R., Steffann J. After the storm — a responsible path for genome editing. N. Engl. J. Med. 2019;380:897–899. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
